Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept Full Text
Clinical Ophthalmology, 07/27/2012
Clinical Article
Stewart MW – Aflibercept promises to decrease the injection frequency required for many patients and appears to serve as an effective “salvage” therapy for patients who respond poorly to other anti–vascular endothelial growth factor drugs.



